Jeremy Bender
Director; Director, CHIEF EXECUTIVE OFFICER · 6 filings · Latest: Jul 28, 2026
Aura Biosciences, Inc.
Bicara Therapeutics Inc.
Day One Biopharmaceuticals, Inc.
Mereo BioPharma Group plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DAWN | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Feb 17, 2026 | Sale | $11.60 | 15,459 | $179.3K | 204,603 | |
DAWN | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Feb 15, 2026 | Option Exercise | — | 42,937 | — | 220,102 | |
DAWN | JEREMY BENDER | — | Feb 17, 2026 | Proposed Sale | $11.60 | 15,459 | $179.3K | — | |
DAWN | JEREMY BENDER | — | Nov 17, 2025 | Proposed Sale | $8.91 | 15,894 | $141.7K | — | |
DAWN | JEREMY BENDER | — | Aug 18, 2025 | Proposed Sale | $6.77 | 16,058 | $108.7K | — | |
DAWN | JEREMY BENDER | — | May 16, 2025 | Proposed Sale | $6.26 | 13,964 | $87.4K | — | |
DAWN | JEREMY BENDER | — | Feb 18, 2025 | Proposed Sale | $11.96 | 12,048 | $144.1K | — | |
DAWN | JEREMY BENDER | — | Nov 18, 2024 | Proposed Sale | $13.21 | 10,554 | $139.4K | — |